A Phase II Trial Assessing the Tolerability and Pharmacodynamic Effect of US SLIT Cat Hair in Subject With Cat Allergy and Investigating Efficacy Variables in an Environmental Exposure Chamber Model.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cat allergy immunotherapy (Primary)
- Indications Hypersensitivity; Rhinoconjunctivitis
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 18 Aug 2010 Biomarkers information updated
- 17 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2009 New trial record